U.S. federal trademark · Serial No. 74052589 · Reg. No. A1402276
antibody-based therapeutic pharmaceutical and veterinary preparations comprising antibody fragments for use in cancer treatment, tumour therapy, modification of the biological activity of lymphokines and site specific targeting of biologically active substances, for treatment of humans, domestic pets, livestock and wild animals
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.